1. Home
  2. NAD vs TXG Comparison

NAD vs TXG Comparison

Compare NAD & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Quality Municipal Income Fund

NAD

Nuveen Quality Municipal Income Fund

HOLD

Current Price

$12.21

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$17.99

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAD
TXG
Founded
1999
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
NAD
TXG
Price
$12.21
$17.99
Analyst Decision
Hold
Analyst Count
0
14
Target Price
N/A
$16.39
AVG Volume (30 Days)
595.7K
2.7M
Earning Date
01-01-0001
02-12-2026
Dividend Yield
4.35%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$642,823,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.25
52 Week Low
$9.56
$6.78
52 Week High
$11.64
$23.56

Technical Indicators

Market Signals
Indicator
NAD
TXG
Relative Strength Index (RSI) 61.23 42.95
Support Level $11.97 $17.26
Resistance Level $12.24 $19.43
Average True Range (ATR) 0.09 1.21
MACD 0.02 -0.39
Stochastic Oscillator 97.30 16.93

Price Performance

Historical Comparison
NAD
TXG

About NAD Nuveen Quality Municipal Income Fund

Nuveen Quality Municipal Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income exempted from regular federal income tax by investing in tax-exempt municipal securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: